Cwm LLC Buys 4,970 Shares of Maximus, Inc. $MMS

Key Points

• Cwm LLC increased its holdings in Maximus, Inc. by 218.6%, acquiring an additional 4,970 shares, bringing their total to 7,244 shares valued at approximately $509,000.
• Insider Michelle F. Link sold 1,610 shares of Maximus at an average price of $90.86, reducing her ownership by 10.65% and retaining 13,508 shares valued at $1,227,336.88.
• Analysts have upgraded Maximus to a "buy" rating, with a consensus price target of $90.00 and recent earnings exceeding expectations, posting $2.16 EPS against a forecast of $1.39.

Cwm LLC increased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 218.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,244 shares of the health services provider's stock after purchasing an additional 4,970 shares during the quarter. Cwm LLC's holdings in Maximus were worth $509,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of MMS. GAMMA Investing LLC grew its stake in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Maximus by 70.5% in the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after purchasing an additional 4,196 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of Maximus by 24.0% in the first quarter. Oppenheimer Asset Management Inc. now owns 6,461 shares of the health services provider's stock worth $441,000 after purchasing an additional 1,249 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its stake in shares of Maximus by 6.4% in the first quarter. Robeco Institutional Asset Management B.V. now owns 27,252 shares of the health services provider's stock worth $1,858,000 after purchasing an additional 1,637 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total transaction of $146,284.60. Following the completion of the transaction, the insider directly owned 13,508 shares in the company, valued at approximately $1,227,336.88. This trade represents a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MMS. Weiss Ratings raised Maximus from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, October 8th. Zacks Research raised Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $90.00.

Maximus Stock Performance

Shares of MMS opened at $87.61 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.73. The company has a 50-day simple moving average of $87.82 and a two-hundred day simple moving average of $77.32. The firm has a market capitalization of $4.94 billion, a PE ratio of 16.13 and a beta of 0.57.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the business earned $1.74 earnings per share. The business's revenue was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, November 14th. Maximus's dividend payout ratio (DPR) is presently 22.10%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.